Expertise in
5
conditions

Anthony M. Brade

Hamilton, ON, CA 
Expertise in
5
conditions
Hamilton, ON, CA 

Overview

Anthony Brade practices practicing medicine in Hamilton, Canada.

Mr. Brade is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Esophagitis, and Thymic Epithelial Tumor.

He is actively involved in clinical research, co-authoring 50 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Hamilton, ON, Canada
Other Locations
Toronto, ON M5T1P5, Canada
Mississauga, ON, Canada
10 Stuart Street, Kingston, ON K7L3N6, Canada
Toronto, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of 4-10 Oligometastatic Tumors (SABR-COMET 10)
A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of 4-10 Oligometastatic Tumors (SABR-COMET 10)
Enrollment Status: Active_not_recruiting
Publish Date: September 18, 2025
Intervention Type: Drug, Other, Radiation
Study Phase: Phase 3
A Phase II, Multi-Centre Study, of Stereotactic Radiotherapy for Oligo-Progression in Metastatic Renal Cell Cancer Patients Receiving 1st Line Sunitinib Therapy
A Phase II, Multi-Centre Study, of Stereotactic Radiotherapy for Oligo-Progression in Metastatic Renal Cell Cancer Patients Receiving 1st Line Sunitinib Therapy
Enrollment Status: Completed
Publish Date: March 23, 2021
Intervention Type: Radiation
Study Phase: Phase 2
View 1 Less Clinical Trial

50 Total Publications

Consensus recommendations on surveillance and survivorship for patients with unresectable/stage IV non-small cell lung cancer after completing Immunotherapy: a Delphi study by Canadian experts.
Consensus recommendations on surveillance and survivorship for patients with unresectable/stage IV non-small cell lung cancer after completing Immunotherapy: a Delphi study by Canadian experts.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: May 07, 2026

Frequently Asked Questions about Anthony M. Brade

Is Anthony M. Brade a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Anthony M. Brade is classified as an Advanced expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Anthony M. Brade participate in research or clinical trials?

Yes. Anthony M. Brade has published 50 articles and abstracts on conditions like Lung Cancer. You can view a list of Anthony M. Brade's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Brade's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile